NEXENTIS TECHNOLOGIES INC NXTS

US Healthcare Pharmaceutical Preparations
$4.30
-3.6%
52w: $3.71 – $82.32

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
3.7143.0282.32
Jun 20, 2025 Jul 2, 2026
Institutional holders
9
+1 QoQ
13F value
$73K
-31.7% QoQ
Smart-money holders
1
signal tier ≥ 2
New smart buyers
1
Q1 2026

Institutional value by quarter

$150K
Q3 2025
$106K
Q4 2025
$73K
Q1 2026

Number of holders

8
Q3 2025
8
Q4 2025
9
Q1 2026

Who owns NXTS?

Q1 2026 filings
FundTypeSharesValue% of fundChange
GEODE CAPITAL MANAGEMENT, LLC Index provider49.8K$31K0.0%New
XTX Topco Ltd Market maker21.8K$14K0.0%New
Yorkville Advisors Global, LP ★2Fundamental concentrated16.4K$11K0.0%New
UBS Group AG Bank broker13.1K$9K0.0%+614.2%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical7.0K$5K0.0%
Tower Research Capital LLC (TRC) Market maker4.5K$3K0.0%+363.6%
SBI Securities Co., Ltd. Diversified mechanical58$380.0%New
MORGAN STANLEY Bank broker5$30.0%Held
Caitong International Asset Management Co., Ltd Diversified mechanical1$10.0%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.